论文部分内容阅读
AIM To review and assess the evidence related tocetuximab treatment in metastatic colorectal cancer(mCRC) with regard to KRAS status.METHODS: PubMed, EMBASE, Cochrane databaseand American Society of Clinical Oncology meetingabstracts were searched for ran